Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer

Cancer Lett. 2013 Nov 1;340(2):227-33. doi: 10.1016/j.canlet.2012.11.008. Epub 2012 Nov 27.

Abstract

Advances in our understanding of the human genome and next-generation technologies have facilitated the use of genome-wide sequencing to decipher the genetic basis of Mendelian disease and hereditary cancer syndromes. However, the application of genome-wide sequencing in hereditary cancer syndromes has had mixed success, in part, due to complex nature of the underlying genetic architecture. In this review we discuss the use of genome-wide sequencing in both Mendelian diseases and hereditary cancer syndromes, highlighting the potential and challenges of this approach using familial pancreatic cancer as an example.

Keywords: Cancer predisposition genes; Genome sequencing; Hereditary cancer.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics*
  • Carcinoma / diagnosis
  • Carcinoma / genetics*
  • Carcinoma / therapy
  • Computational Biology
  • Gene Expression Regulation, Neoplastic
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Genome, Human*
  • Genome-Wide Association Study
  • Genomics / methods*
  • Heredity
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / genetics*
  • Pancreatic Neoplasms / therapy
  • Pedigree
  • Phenotype
  • Precision Medicine
  • Predictive Value of Tests
  • Prognosis
  • Sequence Analysis, DNA*

Substances

  • Biomarkers, Tumor

Supplementary concepts

  • Pancreatic carcinoma, familial